Full Paper
with distilled water (3.0 mL) and the aqueous layer was extracted
with toluene (35.0 mL). The combined organic layers were dried
over magnesium sulfate, filtered, and concentrated in vacuo. Re-
crystallization from diethyl ether gave the target molecule as color-
less crystals (20.3 mg, 0.092 mmol, 28%).
(dd, J=8.5, 2.1 Hz, 1H, H-2), 7.04 (td, J=8.8, 2.1 Hz, 1H, H-4), 3.62
(t, J=6.5 Hz, 2H, H-13), 3.12–2.99 (m, 3H, H-8,10), 2.53 (t, J=
7.1 Hz, 2H, H-11), 2.23–2.09 (m, 2H, H-10), 2.09–2.02 (m, 4H, H-9),
1.98 ppm (q, J=6.8 Hz, 2H, H-12); 13C NMR (100 MHz, CDCl3,
CHCl3 =77.16 ppm): d=164.2 (d, J=250.6 Hz, C-3), 164.0 (d, J=
13.6 Hz, C-1), 161.18 (d, J=0.8 Hz, C-7), 122.7 (d, J=11.1 Hz, C-5),
117.4 (d, J=1.3 Hz, C-6), 112.4 (d, J=23.3 Hz, C-4), 97.5 (d, J=
26.7 Hz, C-2), 55.8 (C-11), 53.7 (C-10), 43.4 (C-13), 34.7 (C-8), 30.7 (C-
9), 30.2 ppm (C-12); Tmp: slow decomposition starting at 1708C;
HRMS (LCT): m/z calcd for C15H19FN2OCl+: 297.1170 [M+H]+;
found: 297.1168.
Synthesis in a flow system: (2,4-Difluorophenyl)piperidine-4-ylme-
thanonoxim acetate (500 mg, 1.67 mmol, 1.0 eq, 0.21m) was dis-
solved in ethanol (6.0 mL) and potassium hydroxide (2.0 mL) solu-
tion (50% in water, 21.60 mmol, 12.9 equiv) was added. The solu-
tion was injected into the loop and pumped through a 1/4“ steel
reactor (V=1.5 mL) with distilled water at 0.2 mLminÀ1. The reactor
was heated by a medium frequency field to 110 8C and pressurized
to 2.0 MPa. The collected reaction solution was extracted with tolu-
ene (325 mL), the combined organic layers were dried over mag-
nesium sulfate, filtered, and concentrated in vacuo. Recrystalliza-
tion from diethyl ether gave the target molecule as colorless crys-
tals (323 mg, 1.46 mmol, 88%). 1H NMR (400 MHz, DMSO,
CD2HSOCD3 =2.49 ppm): d=8.41 (s, 1H, H-11), 8.05 (dd, J=8.8,
5.3 Hz, 1H), 7.69 (dd, J=9.1, 2.1 Hz, 1H), 7.34–7.27 (dd, J=8.8,
2.1 Hz, 1H), 3.44 (tt, J=11.4, 3.8 Hz, 1H), 3.28 (d, J=12.7 Hz, 2H),
2.95 (td, J=12.4, 2.8 Hz, 2H), 2.10 (dd, J=13.5, 2.6 Hz, 2H),
1.99 ppm (ddd, J=15.7, 12.8, 3.9 Hz, 2H); 13C NMR (100 MHz,
DMSO, CD2HSOCD3 =40.45 ppm): d=164.3 (dd, J=131.1, 116.9 Hz,
C-3), 164.0 (d, J=14.2 Hz, C-1), 161,6 (C-7) 124.6 (d, J=11.3 Hz, C-
5), 117.9 (d, J=1.2 Hz, C-6), 113.6 (d, J=25.3 Hz, C-4), 98.4 (d, J=
27.4 Hz, C-2), 44.0 (C-10), 32.6 (C-8), 28.4 ppm (C-9); Tmp: 119.38C;
HRMS (LCT): m/z calcd C12H14FN2O+ 221.1090 [M+H]+; found:
221.1091.
Iloperidone (1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperi-
dinyl]propoxy]-3-methoxy-phenyl]ethanone) (9): Synthesis in
a flow system (purification by flash chromatography): 3-(1-(3-Chloro-
propyl)piperidin-4-yl)-6-fluorobenzo[d]isoxazole
(120 mg,
0.40 mmol, 1.2 equiv) was dissolved in CH2Cl2 (1.5 mL) and 4-acyl-
2-methoxyphenol (56 mg, 0.34 mmol, 1.0 equiv) and lithium hy-
droxide solution (850 mL, 1.2m, 1.01 mmol, 3.0 equiv) were added.
The solution was injected into the loop and pumped through a 1/
4“ steel reactor (V=1.5 mL) with distilled water at 0.2 mLminÀ1
.
The reactor was heated by a medium frequency field to 1808C and
pressurized to 4.5 MPa. The collected reaction solution was extract-
ed with CH2Cl2 (315 mL), the combined organic layers were dried
over magnesium sulfate, filtered and concentrated in vacuo. Purifi-
cation by using flash chromatography (ethyl acetate!ethyl ace-
tate/methanol 1:0 to 95:5) gave the target molecule as slightly
yellow crystals (112 mg, 0.27 mmol, 78%).
3-(1-(3-Chloropropyl)piperidin-4-yl)-6-fluorobenzo[d]isoxazole
(16): Synthesis in a flow system: 6-Fluor-3-(piperidin-4-yl)benzo[d]-
isoxazole (200 mg, 0.91 mmol, 1.0 equiv, 0.061m) and 1-bromo-3-
chloropropane (167 mL, 1.82 mmol, 2.0 equiv) were dissolved in
a mixture of CH2Cl2 (10.0 mL) and distilled water (5.0 mL) and lithi-
um hydroxide solution (0.9 mL, 1.2m, 1.09 mmol, 1.2 equiv) was
added. The solution was injected into the loop and pumped
through a 1/4“ steel reactor (V=1.5 mL) with distilled water at
0.5 mLminÀ1. The reactor was heated by a medium frequency in-
ductor to 1258C (125% PWM) and pressurized to 2.0 MPa. The col-
lected reaction solution was extracted with ethyl acetate (3
10 mL), the combined organic layers were dried over magnesium
sulfate, filtered and concentrated in vacuo. Purification via flash
chromatography (petroleum ether!petroleum ether/ethyl acetate
1:9 to 3:7) gave the target molecule as slightly yellow crystals
(180 mg, 0.61 mmol, 67%).
Synthesis in a flow system (catch and release purification): 3-(1-(3-
Chloropropyl)piperidin-4-yl)-6-fluorobenzo[d]isoxazole
(200 mg,
0.67 mmol, 1.0 equiv) was dissolved in toluene (1.0 mL), and 4-acyl-
2-methoxyphenol (111 mg, 0.67 mmol, 1.0 equiv), lithium hydrox-
ide-solution (2.8 mL, 1.2m, 3.37 mmol, 5.0 equiv) and 1.5 mL petro-
leum ether were added. The mixture was injected into the loop
and pumped through a 1/8“ steel reactor (V=1.2 mL) with distilled
water at 0.1 mLminÀ1. The reactor was heated by a high frequency
field to 1808C and pressurized to 4.5 MPa. The reactor was flushed
with additional CH2Cl2 (3.0 mL) after the reaction and CH2Cl2
(5.0 mL) was added to the reaction mixture. The organic layer was
separated from the aqueous layer, injected into a loop and
pumped through a 1/4” steel reactor (V=2.5 mL) filled with silica
gel at 1.0 mLminÀ1 with ethyl acetate. The product was washed
with ethyl acetate (20 mL) and then released by pumping a mixture
of ethyl acetate/methanol 98:2 (8 mL) through the plug silica. Con-
centration in vacuo gave the target molecule as slightly yellow
crystals (184 mg, 0.43 mmol, 64%). 1H NMR (400 MHz, DMSO, not
calibrated because DMSO signal was overlayed): d=7.98 (dd, J=
8.7, 5.3 Hz, 1H, H-5), 7.66 (dd, J=9.1, 1.9 Hz, 1H, H-2), 7.60 (dd, J=
8.4, 1.9 Hz, 1H, H-18), 7.44 (d, J=1.8 Hz, 1H, H-16), 7.26 (td, J=9.3,
2.1 Hz, 1H, H-4), 7.07 (d, J=8.4 Hz, 1H, H-19), 4.11 (t, J=6.3 Hz, 2H,
H-13), 3.83 (s, 3H, H-15’), 3.18–3.05 (m, 1H, H-8), 2.98 (d, J=
11.2 Hz, 2H, H-10), 2.52 (s, 3H, H-17’’), 2.54–2.44 (m, 2H, H-11), 2.11
(t, J=10.9 Hz, 2H, H-10), 2.06–1.74 ppm (m, 6H, H-9, 11, 12);
13C NMR (100 MHz, DMSO, CD2HSOCD3 =40.45 pp): d=197.2 (C-
17’), 164.5 (d, J=247.8 Hz, C-3), 163.9 (d, J=14.2 Hz, C-1), 162.3 (C-
7), 153.4 (C-14), 149.6 (C-15), 130.7 (C-17), 124.6 (d, J=11.4 Hz, C-5),
124.0 (C-18), 118.16 (d, J=1.1 Hz, C-6), 113.3 (d, J=25.3 Hz, C-4),
112.6 (C-19), 111.3 (C-16), 98.2 (d, J=27.3 Hz, C-2), 67.7 (C-13), 56.4
Synthesis in a flow system (2 steps): (2,4-Difluorophenyl)piperidine-
4-ylmethanonoximacetate (400 mg, 1.33 mmol, 1.0 equiv, 0.21m)
and 1-bromo-3-chloropropane (230 mL, 2.33 mmol, 1.75 equiv)
were dissolved in CH2Cl2 (4.0 mL) and lithium hydroxide-solution
(2.8 mL, 1.2m, 3.30 mmol, 2.5 equiv) was added. The solution was
injected into the loop and pumped through a 1/4“ steel reactor
(V=1.5 mL) with distilled water at 0.2 mLminÀ1. The reactor was
heated by a medium frequency field to 1308C and pressurized to
2.0 MPa. 1-bromo-3-chloropropane (230 mL, 2.33 mmol, 1.75 equiv)
and lithium hydroxide solution (1,1 mL, 1.2m, 1.33 mmol, 1.0 equiv)
were added to the collected solution and the mixture was injected
a into the loop for a second run at the same conditions. The col-
lected reaction solution was extracted with ethyl acetate (3
30 mL), the combined organic layers were dried over magnesium
sulfate, filtered and concentrated in vacuo. Purification by using
flash chromatography (petroleum ether!petroleum ether/ethyl
acetate 1:9 to 3:7) gave the target molecule as slightly yellow crys-
tals (300 mg, 1.01 mmol, 76%). 1H NMR (400 MHz, DMSO,
CD2HSOCD3 =2.49 ppm): d=7.68 (dd, J=8.7, 5.1 Hz, 1H, H-5), 7.23
(C-15’), 55.5 (C-11), 53.9 (C-10), 34.4 (C-8), 31.1 (C-9,12), 27.2 ppm
+
(C-17’’); Tmp: 120–1228C; HRMS (LCT): m/z calcd for C24H28FN2O4
:
427.2028 [M+H]+; found: 427.2026.
Chem. Eur. J. 2016, 22, 3044 – 3052
3051
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim